Japan Intellectual Property Rights: USE OF APTAMER IN THERAPY AND/OR DIAGNOSIS OF AUTOIMMUNE DISEASE

Japan, July 14 -- CHARITE-UNIVERSITAETSMEDIZIN BERLIN,MAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZIN has got intellectual property rights for 'USE OF APTAMER IN THERAPY AND/OR DIAGNOSIS OF AUTOIMMUNE DISEASE.' Other related details are as follows:

Application Number: JP,2023-006274

Category (FI): A61P11/00,A61P25/28,A61P9/00,A61P37/06,A61P37/02,A61P27/06,G01N33/53@N,C12N15/115@Z,A61K31/7088,A61P1/00,A61P9/12,A61P17/06,A61P17/00,A61P25/00,A61P13/08

Stage: PROBLEM TO BE SOLVED: To provide a use of an aptamer in therapy and/or diagnosis of an autoimmune disease.SOLUTION: According to the present invention, an aptamer consists of the nucleic acid sequence of SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3, and/or a nucleic acid sequence being at lea...